Skip to main navigation Skip to search Skip to main content

Mechanistic Evaluations on Sorafenib Induced Hypophosphatemia in Patients with Advanced Renal Cell Carcinoma (RCC)

Project: Research

Project Details

StatusFinished
Effective start/end date03/12/09 → 11/18/11

Funding

  • Bayer Healthcare Pharmaceuticals Incorporated: $2,500.00